United States Biotechnology & Medical Research

Exelixis Inc (EXEL)

Track

Over the past 90 days, Exelixis Inc. insiders have engaged in 20 transactions, all of which were sales, totaling approximately $9.6 million in net value. These divestments occurred following a positive earnings report in May. The stock has seen a 20.1% price increase over the last quarter, currently trading near its 52-week high.
Ticker: EXEL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Exelixis Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 1 Jun 2026
Value US$594,603.26 | Price 480.32 | Shares 36,753 (-10.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-01 PlS Planned sale
1.6
WYSZOMIERSKI JACK L
Non-Executive Director
36,753 -10.6%
480.32
US$594,603 		36,753 -10.6% 480.32 US$594,603
2026-06-03 2026-06-01 PlS Planned sale
0.7
Eckhardt Sue Gail
Non-Executive Director
78,597 +31.1%
138.75
US$3,078,279 		78,597 +31.1% 138.75 US$3,078,279
2026-06-01 2026-06-01 PrS Proposed sale
0.7
Eckhardt Sue Gail

Director

Non-Executive Director
29,101
17.92
US$388,289 		29,101 17.92 US$388,289
2026-06-01 2026-06-01 PrS Proposed sale
1.6
JACK L WYSZOMIERSKI

Director

Non-Executive Director
3,925
50.55
US$198,409 		3,925 50.55 US$198,409
2026-05-28 2026-05-26 S Sale
2.4
Aftab Dana

EVP, Research and Development

Officer
43,451 -6.8%
50.35
US$2,187,758 		43,451 -6.8% 50.35 US$2,187,758
2026-05-26 2026-05-26 PrS Proposed sale
2.4
DANA T AFTAB

Officer

Officer
43,451
50.35
US$2,187,758 		43,451 50.35 US$2,187,758
2026-05-22 2026-05-20 S Sale
2.8
Haley Patrick J.

EVP, Commercial

Officer
32,110 -8.2%
49.81
US$1,599,399 		32,110 -8.2% 49.81 US$1,599,399
2026-05-20 2026-05-20 PrS Proposed sale
2.8
PATRICK JOSEPH HALEY

Officer

Officer
32,110
49.81
US$1,599,444 		32,110 49.81 US$1,599,444
2026-05-19 2026-05-18 PlS Planned sale
Hefti Brenda

SVP and General Counsel

Officer
6,625 -5.8%
50.21
US$332,641 		6,625 -5.8% 50.21 US$332,641
2026-05-19 2026-05-18 S Sale
3.1
Senner Christopher J.

EVP and CFO

Officer
34,901 -3.5%
50.00
US$1,745,050 		34,901 -3.5% 50.00 US$1,745,050
2026-05-18 2026-05-18 PrS Proposed sale
3.1
CHRISTOPHER J SENNER

Officer

Officer
34,901
50.00
US$1,745,179 		34,901 50.00 US$1,745,179
2026-05-18 2026-05-18 PrS Proposed sale
BRENDA JOY HEFTI

Officer

Officer
6,625
50.21
US$332,641 		6,625 50.21 US$332,641
2026-05-18 2026-05-18 PrS Proposed sale
BRENDA JOY HEFTI

Officer

Officer
6,625
50.21
US$332,641 		6,625 50.21 US$332,641
2026-05-14 2026-05-14 PrS Proposed sale
BOMBORA RISE FOUNDATION

Family foundation of the CEO of EXEL.
100,000
50.91
US$5,091,190 		100,000 50.91 US$5,091,190
2026-05-08 2026-05-07 S Sale
2.4
Freire Maria C
Non-Executive Director
20,634 -17.0%
46.00
US$949,164 		20,634 -17.0% 46.00 US$949,164
2026-05-08 2026-05-07 S Sale
2.7
Beckerle Mary C
Non-Executive Director
7,712 -30.6%
48.45
US$373,646 		7,712 -30.6% 48.45 US$373,646
2026-05-08 2026-05-07 S Sale
2.7
POSTE GEORGE
Non-Executive Director
60,000 -33.6%
45.71
US$2,742,600 		60,000 -33.6% 45.71 US$2,742,600
2026-05-07 2026-05-07 PrS Proposed sale
2.7
MARY BECKERLE

Director

Non-Executive Director
7,712
48.45
US$373,646 		7,712 48.45 US$373,646
2026-05-07 2026-05-07 PrS Proposed sale
2.7
GEORGE H POSTE

Director

Non-Executive Director
60,000
45.71
US$2,742,468 		60,000 45.71 US$2,742,468
2026-05-07 2026-05-07 PrS Proposed sale
2.4
MARIA C FREIRE

Director

Non-Executive Director
20,634
46.00
US$949,164 		20,634 46.00 US$949,164
2026-02-26 2026-02-24 S Sale
2.4
Aftab Dana

EVP, Research and Development

Officer
47,918 -7.2%
44.50
US$2,132,351 		47,918 -7.2% 44.50 US$2,132,351
2026-02-24 2026-02-24 PrS Proposed sale
2.4
DANA T AFTAB

Officer

Officer
47,918
44.50
US$2,132,351 		47,918 44.50 US$2,132,351
2026-02-23 2026-02-19 S Sale
2.4
Aftab Dana

EVP, Research and Development

Officer
29,873 -4.3%
44.35
US$1,324,868 		29,873 -4.3% 44.35 US$1,324,868
2026-02-19 2026-02-19 PrS Proposed sale
2.4
DANA T AFTAB

Officer

Officer
29,873
44.35
US$1,324,868 		29,873 44.35 US$1,324,868
2026-02-20 2026-02-18 PlS Planned sale
1.6
WYSZOMIERSKI JACK L
Non-Executive Director
99,574 -26.2%
44.01
US$4,382,252 		99,574 -26.2% 44.01 US$4,382,252
2026-02-19 2026-02-18 S Sale
2.2
Smith Julie
Non-Executive Director
20,030 -49.3%
44.30
US$887,329 		20,030 -49.3% 44.30 US$887,329
2026-02-19 2026-02-18 S Sale
2.2
Smith Julie
Non-Executive Director
44,087 -68.2%
44.50
US$1,961,872 		44,087 -68.2% 44.50 US$1,961,872
2026-02-18 2026-02-18 PlS Planned sale
Hefti Brenda

SVP and General Counsel

Officer
18,669 -16.2%
44.01
US$821,623 		18,669 -16.2% 44.01 US$821,623
2026-02-18 2026-02-18 PrS Proposed sale
2.2
JULIE ANNE SMITH

Director

Non-Executive Director
64,117
44.44
US$2,849,200 		64,117 44.44 US$2,849,200
2026-02-18 2026-02-18 PrS Proposed sale
BRENDA JOY HEFTI

Officer

Officer
18,669
44.01
US$821,664 		18,669 44.01 US$821,664
2026-02-18 2026-02-18 PrS Proposed sale
1.6
JACK L WYSZOMIERSKI

Director

Non-Executive Director
99,574
44.01
US$4,382,507 		99,574 44.01 US$4,382,507
2026-02-19 2026-02-17 S Sale
2.2
Smith Julie
Non-Executive Director
42,422 -67.3%
43.33
US$1,838,145 		42,422 -67.3% 43.33 US$1,838,145
2026-02-18 2026-02-17 S Sale
2.8
Haley Patrick J.

EVP, Commercial

Officer
64,778 -14.5%
43.50
US$2,817,843 		64,778 -14.5% 43.50 US$2,817,843
2026-02-18 2026-02-17 S Sale
2.8
Haley Patrick J.

EVP, Commercial

Officer
3,036 -0.7%
43.84
US$133,098 		3,036 -0.7% 43.84 US$133,098
2026-02-18 2026-02-17 S Sale
3.1
Senner Christopher J.

EVP and CFO

Officer
30,617 -3.0%
43.67
US$1,337,044 		30,617 -3.0% 43.67 US$1,337,044
2026-02-17 2026-02-17 PrS Proposed sale
2.2
JULIE ANNE SMITH

Director

Non-Executive Director
42,422
44.33
US$1,880,440 		42,422 44.33 US$1,880,440
2026-02-17 2026-02-17 PrS Proposed sale
3.1
CHRISTOPHER J SENNER

Officer

Officer
30,617
43.67
US$1,337,035 		30,617 43.67 US$1,337,035
2026-02-17 2026-02-17 PrS Proposed sale
2.8
PATRICK JOSEPH HALEY

Officer

Officer
67,814
43.52
US$2,951,083 		67,814 43.52 US$2,951,083
2026-02-18 2026-02-13 PlS Planned sale
0.7
Eckhardt Sue Gail
Non-Executive Director
3,856 -18.0%
43.79
US$168,854 		3,856 -18.0% 43.79 US$168,854
2026-02-18 2026-02-13 S Sale
1.9
Oliver Bob
Non-Executive Director
21,162 -50.0%
43.90
US$929,012 		21,162 -50.0% 43.90 US$929,012
2026-02-18 2026-02-13 S Sale
1.9
Oliver Bob
Non-Executive Director
9,088 -17.7%
43.61
US$396,328 		9,088 -17.7% 43.61 US$396,328
2026-02-18 2026-02-13 S Sale
3.1
Senner Christopher J.

EVP and CFO

Officer
34,278 -3.2%
43.00
US$1,473,954 		34,278 -3.2% 43.00 US$1,473,954
2026-02-13 2026-02-13 PrS Proposed sale
0.7
Eckhardt Sue Gail

Director

Non-Executive Director
3,856
42.89
US$165,384 		3,856 42.89 US$165,384
2026-02-13 2026-02-13 PrS Proposed sale
1.9
ROBERT L OLIVER

Director

Non-Executive Director
30,250
43.82
US$1,325,408 		30,250 43.82 US$1,325,408
2026-02-13 2026-02-13 PrS Proposed sale
3.1
CHRISTOPHER J SENNER

Officer

Officer
34,278
43.00
US$1,473,964 		34,278 43.00 US$1,473,964
2026-02-12 2026-02-12 PrS Proposed sale
BOMBORA RISE FOUNDATION

Family foundation of the CEO of EXEL.
5,000
43.25
US$216,250 		5,000 43.25 US$216,250
2025-11-26 2025-11-25 B Purchase
3.6
JOHNSON DAVID EDWARD
Non-Executive Director
27,532 +1.8%
43.12
US$1,187,235 		27,532 +1.8% 43.12 US$1,187,235
2025-12-12 2025-11-21 PrS Proposed sale
2.8
Haley Patrick J.

Officer; Member of immediate family of any of the foregoing

Officer
28,043
42.51
US$1,192,108 		28,043 42.51 US$1,192,108
2025-11-24 2025-11-21 S Sale
2.8
Haley Patrick J.

EVP, Commercial

Officer
28,043 -7.0%
42.58
US$1,194,071 		28,043 -7.0% 42.58 US$1,194,071
2025-12-12 2025-11-20 PrS Proposed sale
2.8
Haley Patrick J.

Officer; Member of immediate family of any of the foregoing

Officer
23,539
41.78
US$983,459 		23,539 41.78 US$983,459
2025-12-12 2025-11-20 PrS Proposed sale
2.8
Haley Patrick J.

Officer; Member of immediate family of any of the foregoing

Officer
10,648
41.78
US$444,873 		10,648 41.78 US$444,873
2025-11-24 2025-11-20 S Sale
2.8
Haley Patrick J.

EVP, Commercial

Officer
10,648 -100.0%
41.77
US$444,767 		10,648 -100.0% 41.77 US$444,767
2025-11-24 2025-11-20 S Sale
2.8
Haley Patrick J.

EVP, Commercial

Officer
23,539 -100.0%
41.93
US$986,990 		23,539 -100.0% 41.93 US$986,990
2025-11-24 2025-11-20 S Sale
2.8
Haley Patrick J.

EVP, Commercial

Officer
10,000 -2.4%
42.11
US$421,100 		10,000 -2.4% 42.11 US$421,100
2025-11-20 2025-11-20 PrS Proposed sale
2.8
PATRICK JOSEPH HALEY

Officer

Officer
10,000
42.11
US$421,052 		10,000 42.11 US$421,052
2025-11-13 2025-11-13 PrS Proposed sale
3.4
JEFFREY J HESSEKIEL

Officer

Officer
40,000
43.15
US$1,726,128 		40,000 43.15 US$1,726,128
2025-11-13 2025-11-12 S Sale
3.7
PAPADOPOULOS STELIOS
Non-Executive Director
100,000 -7.8%
43.55
US$4,355,000 		100,000 -7.8% 43.55 US$4,355,000
2025-11-12 2025-11-12 PrS Proposed sale
3.7
Stelios Papadopoulos

Director

Non-Executive Director
100,000
43.55
US$4,355,204 		100,000 43.55 US$4,355,204
2025-11-12 2025-11-12 PrS Proposed sale
3.4
JEFFREY J HESSEKIEL

Officer

Officer
60,000
43.02
US$2,581,006 		60,000 43.02 US$2,581,006
2025-11-13 2025-11-11 S Sale
2.7
Beckerle Mary C
Non-Executive Director
18,838 -46.8%
41.90
US$789,312 		18,838 -46.8% 41.90 US$789,312
2025-11-13 2025-11-11 S Sale
2.7
Beckerle Mary C
Non-Executive Director
5,784 -12.6%
42.03
US$243,102 		5,784 -12.6% 42.03 US$243,102
2025-11-13 2025-11-11 S Sale
2.4
Aftab Dana

EVP, Research and Development

Officer
48,383 -6.8%
42.50
US$2,056,278 		48,383 -6.8% 42.50 US$2,056,278
2025-11-12 2025-11-11 PrS Proposed sale
2.4
DANA T AFTAB

Officer

Officer
48,383
42.50
US$2,056,360 		48,383 42.50 US$2,056,360
2025-11-12 2025-11-11 PrS Proposed sale
2.7
MARY BECKERLE

Director

Non-Executive Director
24,622
41.93
US$1,032,436 		24,622 41.93 US$1,032,436
2025-06-04 2025-06-03 PlS Planned sale
1.6
WYSZOMIERSKI JACK L
Non-Executive Director
7,535 -2.1%
43.09
US$324,683 		7,535 -2.1% 43.09 US$324,683
2025-06-03 2025-06-03 PrS Proposed sale
1.6
JACK L WYSZOMIERSKI

Director

Non-Executive Director
7,535
43.09
US$324,658 		7,535 43.09 US$324,658
2025-06-04 2025-06-02 PlS Planned sale
0.7
Eckhardt Sue Gail
Non-Executive Director
4 -0.0%
43.67
US$175 		4 -0.0% 43.67 US$175
2025-06-04 2025-06-02 PlS Planned sale
0.7
Eckhardt Sue Gail
Non-Executive Director
18,834 -46.8%
42.74
US$804,965 		18,834 -46.8% 42.74 US$804,965
2025-06-02 2025-06-02 PrS Proposed sale
0.7
Eckhardt Sue Gail

Director

Non-Executive Director
18,838
43.54
US$820,206 		18,838 43.54 US$820,206
2025-05-22 2025-05-21 S Sale
3.7
Heyman Tomas J.
Non-Executive Director
4,544 -12.3%
44.29
US$201,254 		4,544 -12.3% 44.29 US$201,254
2025-05-21 2025-05-21 PrS Proposed sale
3.7
Heyman Tomas J.

Director

Non-Executive Director
4,544
44.29
US$201,259 		4,544 44.29 US$201,259
2025-05-22 2025-05-20 S Sale
2.8
Haley Patrick J.

EVP, Commercial

Officer
34,387 -7.7%
44.06
US$1,515,091 		34,387 -7.7% 44.06 US$1,515,091
2025-05-20 2025-05-20 PrS Proposed sale
2.8
PATRICK JOSEPH HALEY

Officer

Officer
34,387
44.06
US$1,514,998 		34,387 44.06 US$1,514,998
2025-05-16 2025-05-16 PrS Proposed sale
3.7
AMY PETERSON

Officer

Officer
72,776
46.26
US$3,366,618 		72,776 46.26 US$3,366,618
2025-05-16 2025-05-16 PrS Proposed sale
3.1
CHRISTOPHER J SENNER

Officer

Officer
100,000
46.00
US$4,600,000 		100,000 46.00 US$4,600,000
Explore more

More insider trading research around Exelixis Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America